NCT03619603

Brief Summary

To identifying biomarkers in patients with pneumonia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
272

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 8, 2018

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

8 years

First QC Date

July 26, 2018

Last Update Submit

March 20, 2026

Conditions

Pneumonia

Outcome Measures

Primary Outcomes (1)

  • mortality

    Mortality is defined the patient died in hospital.

    From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first

Secondary Outcomes (2)

  • severe pneumonia

    From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first

  • initial treatment failure

    From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with pneumonia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Chongqing Medical University

Chongqing, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood, secretions and tissues.

MeSH Terms

Conditions

Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Jun Duan, MD

    First Affiliated Hospital of Chongqing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 26, 2018

First Posted

August 8, 2018

Study Start

January 1, 2018

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 23, 2026

Record last verified: 2026-03

Locations

CN(1)